October 17, 2025 · Form 4 insider transaction
GOLDSMITH MARK A sold 10,000 shares of Revolution Medicines, Inc. at $55.00 per share, a transaction worth $550.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 193,475 restricted stock units.